Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells
about
Flavivirus NS1: a multifaceted enigmatic viral proteinJapanese encephalitis: the virus and vaccinesFlavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune SystemStructural basis of Flavivirus NS1 assembly and antibody recognitionEnzyme-linked immunosorbent assay-format tissue culture infectious dose-50 test for titrating dengue virusProtection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation.Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.The C Terminus of the Core β-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.Complement alternative pathway genetic variation and Dengue infection in the Thai populationNon-structural protein-1 is required for West Nile virus replication complex formation and viral RNA synthesis.Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression.West Nile virus infection and immunity.Non-Canonical Roles of Dengue Virus Non-Structural Proteins.A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection.Complement-dependent cytotoxicity assay for differentiating West Nile virus from Japanese encephalitis virus infections in horses.Multiple amino acid variations in the nonstructural proteins of swine Japanese encephalitis virus alter its virulence in mice.Structural study of the C-terminal domain of non-structural protein 1 from Japanese encephalitis virus.Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E proteinDengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidateHuman antibodies targeting Zika virus NS1 provide protection against disease in a mouse modelJapanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses
P2860
Q26247192-C5EF2F8A-0B70-4D6E-8F1D-298FAB7E36B6Q27010434-699000A4-8FDC-4FA3-AB36-6DA5AE2F970CQ27681625-85383F78-BA25-4A20-BFB5-2A8B49DFCA10Q27681981-4411A23C-73BF-4A32-85FA-DA594943EE9FQ31028311-1BA24EF7-CCEC-42A9-A680-27DD0A26CAB1Q33414156-B6310E33-6796-42B2-88BB-CA1AD9F58418Q35058899-EE359C88-1E2E-4D98-8A04-2AA0DDD9F200Q36156558-68985840-8CC6-445C-891D-F0FA8CB548C3Q36481508-F9DBF004-E638-4ED0-B3E4-04EC992EAAFCQ37310565-32560CD7-150D-4C2E-88D0-B0B479D09E3AQ37348012-A63E7472-53EF-47DD-B260-D17138397B6FQ37540534-717698F7-5F3C-4BDC-AE1D-63AF5F6A7437Q38074266-D1230C2F-1C8D-423B-8E92-7CAA53A7EE70Q39196605-1B1AA593-D328-4524-92BD-2AC7A950A4B4Q39686453-14644945-D758-447F-91B9-C5469037B3BFQ40039016-73F02A65-31E8-4DF0-88CB-6B1101475713Q40326488-7FA3830C-4BB3-445F-AC96-D488AA9846D7Q43032117-EEE4DC0C-F5FC-4A91-8BE0-B7C7D34DF6E6Q47552236-937E3D9E-2B80-45C1-9D31-BF47EDD0E4A4Q56000963-DFF0688C-1ED9-45F5-8248-494F8654DC86Q56396121-789E15EB-6E19-49B2-9BA2-A8A711E7229AQ58569620-1941C2AC-CE1E-4EDC-8881-F86871870AD9Q58999704-BB8E1CD4-0B2E-480F-AEA1-76FECF814CA3
P2860
Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells
description
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2009-05)
@fr
articolo scientifico (pubblicato il 2009-05)
@it
artigo científico (publicado na 2009-05)
@pt
artículu científicu espublizáu en 2009
@ast
im Mai 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: May 2009)
@en
vedecký článok (publikovaný 2009-05)
@sk
videnskabelig artikel (udgivet 2009-05)
@da
name
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@ast
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@en
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@nl
type
label
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@ast
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@en
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@nl
prefLabel
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@ast
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@en
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Virus-Specific Cytolytic Antib ...... rus Output from Infected Cells
@en
P2093
Manjuladevi Rangappa
Venkatramana D Krishna
Vijaya Satchidanandam
P2860
P304
P3181
P356
10.1128/JVI.01850-08
P577
2009-05-01T00:00:00Z